Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 7:528-536

David Geffen School of Medicine at UCLA, 10833 LeConte Avenue, Los Angeles, CA 90095-1679, USA.
Nature Reviews Cardiology (Impact Factor: 10.15). 09/2010; 7(9):528-36. DOI: 10.1038/nrcardio.2010.115
Source: PubMed

ABSTRACT In the past decade, the prevalence, significance, and regulatory mechanisms of vascular calcification have gained increasing recognition. Over a century ago, pathologists recognized atherosclerotic calcification as a form of extraskeletal ossification. Studies are now identifying the mechanism of this remarkable process as a recapitulation of embryonic endochondral and membranous ossification through phenotypic plasticity of vascular cells that function as adult mesenchymal stem cells. These embryonic developmental programs, involving bone morphogenetic proteins and potent osteochondrogenic transcription factors, are triggered and modulated by a variety of inflammatory, metabolic, and genetic disorders, particularly hyperlipidemia, chronic kidney disease, diabetes, hyperparathyroidism, and osteoporosis. They are also triggered by loss of powerful inhibitors, such as fetuin A, matrix Gla protein, and pyrophosphate, which ordinarily restrict biomineralization to skeletal bone. Teleologically, soft-tissue calcification might serve to create a wall of bone to sequester noxious foci such as chronic infections, parasites, and foreign bodies. This Review focuses on atherosclerotic and medial calcification. The capacity of the vasculature to produce mineral in culture and to produce de novo, vascularized, trabecular bone and cartilage tissue, even in patients with osteoporosis, should intrigue investigators in tissue engineering and regenerative biology.

  • Source
    • "1998 ) , whereas MGP seems to exert a more generalized function to prevent tissue calcification in cartilage ( Yagami et al . 1999 ) and in the vascular system ( Bostrom and Demer 2000 ) . We have observed an increase in ECM mineral - ization when warfarin , a known inhibitor of g - carboxyl - ation ( Berkner 2000 ) is added to the culture medium of VSa cells , suggesting the involvement of Gla - containing proteins ( most probably MGP in VSa13 and osteocalcin in VSa16 cells ) in mechanisms controlling nodule for - mation . "
    [Show abstract] [Hide abstract]
    ABSTRACT: A growing interest in the understanding of the ontogeny and mineralization of fish skeleton has emerged from the recent implementation of fish as a vertebrate model, particularly for skeletal development. Whereas several in vivo studies dealing with the regulation of bone formation in fish have been published, in vitro studies have been hampered because of a complete lack of fish-bone-derived cell systems. We describe here the development and the characterization of two new cell lines, designated VSa13 and VSa16, derived from the vertebra of the gilthead sea bream. Both cell types exhibit a spindle-like phenotype and slow growth when cultured in Leibovitz's L-15 medium and a polygonal phenotype and rapid growth in Dulbecco's modified Eagle medium (D-MEM). Scanning electron microscopy and von Kossa staining have revealed that the VSa13 and VSa16 cells can only mineralize their extracellular matrix when cultured in D-MEM under mineralizing conditions, forming calcium-phosphate crystals similar to hydroxyapatite. We have also demonstrated the involvement of alkaline phosphatase, a marker of bone formation in vivo, and Gla proteins (osteocalcin and matrix Gla protein, MGP) in the process of mineralization. Finally, we have shown that VSa13 and VSa16 cell lines express osteocalcin and MGP in a mutually exclusive manner. Thus, both cell lines are capable of mineralizing in vitro and of expressing genes found in chondrocyte and osteoblast cell lineages, emphasizing the suitability of these new cell lines as valuable tools for analyzing the expression and regulation of cartilage- and bone-specific genes.
    Cell and Tissue Research 04/2004; 315(3):393-406. DOI:10.1007/s00441-003-0830-1 · 3.33 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Significant scientific and clinical advances have been achieved in the study of vascular calcification during the last 10 years. Vascular calcification occurs frequently in atheromas and carries significant risk for future cardiac events due to stenotic and hemodynamic effects. The constituents of bone matrix and mineralization are present in atherosclerotic lesions, and a population of cells that secrete these products in vitro has been identified. The phenotype of these cells and their capacity to secrete osteoid are under the control of numerous inflammatory mediators and are thought to be regulated by similar molecular mechanisms as osteogenesis. Clinically, further studies are required to precisely define the prevalence of vascular calcification and its correlation with atherosclerotic disease, including risk factors for atherothrombotic disease such as smoking, diabetes, dyslipidemia, and sedentary lifestyle. Many other issues remain to be addressed including the following: the origin of subpopulations of progenitor cells within the arterial tree, other differentiation capacity of these progenitor cells, factors that control their migration, and the presence of a common molecular regulatory motif of bone development linking atherogenesis and osteoporosis.
    Journal of Nuclear Cardiology 03/2003; 10(2):177-83. DOI:10.1067/mnc.2003.0012 · 2.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: When examining radiographs of patients with Paget's disease of bone (PD), we often observed calcification of the aorta and iliac or femoral arteries. The processes of extraosseous calcification or mineralization are very close to the mechanisms regulating mineralization of bone tissue. The aim of our study was to quantify the number, extent (length and thickness), and type (arteriosclerotic or medial arterial calcification) of vascular calcification in patients with Paget's disease and to compare them with those of controls, in order to discover whether PD is accompanied by increased calcification. Vascular calcification was quantified on the aorta, the iliac arteries, and their branches, the femoral, gluteal, and pelvic arteries of 42 patients with Paget's disease and 36 control subjects. Of the PD subjects, 52.4% had arteriosclerotic calcification versus 30.6% of controls (P = 0.05), and 38.6% of PD patients had medial arterial calcification versus 11.1% of controls (P = 0.05). The mean length of calcification was greater in PD patients: 1.93 +/- 2.85 cm versus 0.84 +/- 1.69 cm in controls (P = 0.04). The thickness of calcification was also greater in PD patients: 1.24 +/- 1.30 mm versus 0.56 +/- 0.94 mm (P = 0.01). Patients with Paget's disease more frequently had medial arterial or arteriosclerotic calcification than controls. These calcifications were longer and thicker. Our clinical study therefore confirms that abnormal vessel wall calcification and bone remodeling in Paget's disease are probably linked, although the mechanism of this relation is as yet unexplained.
    Calcified Tissue International 10/2005; 77(3):129-33. DOI:10.1007/s00223-005-0250-1 · 2.75 Impact Factor
Show more


Available from